Novavax Inc - Company Profile

Powered by

All the sales intelligence you need on Novavax Inc in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Novavax Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Novavax Inc.

Back to companies

Novavax Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Novavax Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Novavax Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

David M. Mott

Chairman Executive Board Since: 2026 Age: 60

Mr David M. Mott has been the Chairman of the company since 2026. He also serves as the Chief Executive Officer and Chief Investment Officer at Sphinx Mountain Capital LLC. Prior to this, he served as the Chairman at Ardelyx, Inc. from 2008 to 2020. Previously, he served as the president and chief executive officer and vice chairman at MedImmune.

Read Hide full bio of David M. Mott

Margaret G. McGlynn

Vice Chairman Executive Board Since: 2025 Age: 66

Ms. Margaret G. McGlynn has been the Vice chairman of the company since 2025. She also serves as the President and Chairman at HCU Network America. Previously, she served as the president and chief executive officer at International AIDS Vaccine Initiative (IAVI).

Read Hide full bio of Margaret G. McGlynn

John C. Jacobs

Chief Executive Officer; Director; President Executive Board Since: 2023 Age: 59

Mr. John Jacobs has been the Chief Executive Officer, President, and Director of the company since 2023. Prior to this, he served as the President, Director and Chief Executive Officer at Harmony Biosciences Holdings, Inc from 2018 to 2023. Previously, he served as the executive vice president and chief commercial officer at Harmony Biosciences Holdings, Inc from 2017 to 2018. Mr Jacobs served as the senior vice president and general manager of the Respiratory Business Unit, senior vice president of Commercial Operations in North America and general manager at Teva Pharmaceuticals.

Read Hide full bio of John C. Jacobs

James P. Kelly

Executive Vice President; Treasurer; Chief Financial Officer Senior Management Since: 2021 Age: 60

Mr. James P. Kelly has been the Executive Vice President, Chief Financial Officer, and Treasurer of the company since 2021. Prior to this, he served as the Chief Financial officer at Supernus Pharmaceuticals and Vanda Pharmaceuticals. Previously, he served in key finance roles at MedImmune, Biogen and Aetna.

Read Hide full bio of James P. Kelly

Elaine O’Hara

Executive Vice President; Chief Strategy Officer Senior Management Since: 2023 Age: 58

Ms. Elaine O’Hara has been the Executive Vice President and Chief Strategy Officer of the company since 2023. Prior to this, she served as the Chief Commercial Officer at Sanofi Vaccines. Previously, she served as the Senior Vice President, Commercial Operations at Otsuka America Pharmaceuticals Inc. Ms. O’Hara also served as the Senior Director at Pfizer Pharmaceuticals.

Read Hide full bio of Elaine O’Hara
Gain a 360-degree view of Novavax Inc and make more informed decisions for your business Gain a 360-degree view of Novavax Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer